Document is current
Any future updates will be listed below
-
Authors
Pradella, Davide https://orcid.org/0000-0002-8649-7817
Zhang, Minsi
Gao, Rui
Yao, Melissa A. https://orcid.org/0000-0002-2274-6925
Gluchowska, Katarzyna M.
Cendon-Florez, Ylenia https://orcid.org/0000-0001-7525-7407
Mishra, Tanmay
La Rocca, Gaspare
Weigl, Moritz
Jiao, Ziqi
Nguyen, Hieu H. M. https://orcid.org/0000-0001-9195-1757
Lisi, Marta
Ozimek, Mateusz M.
Mastroleo, Chiara
Chen, Kevin https://orcid.org/0000-0002-0674-1411
Grimm, Felix
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Zhang, Shu https://orcid.org/0000-0003-2543-5943
Zolli, Andrea Alice
Sun, Eric G. https://orcid.org/0000-0002-9109-1969
Dameracharla, Bhargavi
Zhao, Zhengqiao
Pritykin, Yuri https://orcid.org/0000-0001-6589-981X
Sigel, Carlie
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
Mischel, Paul S. https://orcid.org/0000-0002-4560-2211
Bafna, Vineet
Antonescu, Cristina R. https://orcid.org/0000-0002-9717-8205
Ventura, Andrea https://orcid.org/0000-0003-4320-9907
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 31 October 2024
First Online: 18 December 2024
Competing interests
: H.Y.C. is a cofounder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics and an advisor for 10x Genomics, Arsenal Biosciences, Chroma Medicine, Exai Bio and Spring Discovery. P.S.M. is a cofounder of, chairs the scientific advisory board of and has equity interest in Boundless Bio. V.B. is a cofounder of, consultant for and SAB member of and has equity interest in Boundless Bio, Inc. and Abterra, Inc. The remaining authors declare no competing interests.
